Recent Finacing
Recent Raise
Procarta Biosystems develops DNA-based therapeutics—injectable Transcription Factor Decoys that inactivate bacterial resistance genes to restore antibiotic efficacy; lead anti‑MRSA program and Gram‑negative pipeline.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
